DZ Bank
CNTA

DZ Bank’s Centessa Pharmaceuticals CNTA Stock Holding History

DZ Bank’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-81,525
Closed -$2.04M – 1015
2025
Q4 		$2.04M Sell
81,525
-34,872
-30% -$883K ﹤0.01% 628
2025
Q3 		$2.82M Sell
116,397
-141,021
-55% -$2.51M ﹤0.01% 574
2025
Q2 		$3.38M Hold
257,418
– – ﹤0.01% 532
2025
Q1 		$3.7M Sell
257,418
-46,061
-15% -$754K ﹤0.01% 494
2024
Q4 		$5.08M Buy
+303,479
New +$5.03M 0.01% 433

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DZ Bank's CNTA Position: Q1 2026 in Review

DZ Bank sold out of Centessa Pharmaceuticals (CNTA) in Q1 2026, closing a stake of 81,525 shares — an estimated $2.04M sold.

DZ Bank first reported a position in CNTA in Q4 2024 and held it in 5 quarters. The position peaked at $5.08M in Q4 2024. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • DZ Bank reported no remaining Centessa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • DZ Bank sold 81,525 Centessa Pharmaceuticals shares in Q1 2026, an estimated $2.04M.
  • DZ Bank first reported a position in Centessa Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • DZ Bank's Centessa Pharmaceuticals position peaked at $5.08M in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.